Citations

Clear

51 citation(s) found for "Sarr, Michael".

Disclosure of Funding Sources and Conflicts of Interest in Phase III Surgical Trials: Survey of 10 General Surgery Journals
Sarr, Michael G. , Warshaw, Andrew L.

Mayo Clinic

World Journal of Surgery | May 22, 2014 | Volume: 38 | Issue: 10 | Pages: 2494-2494

10.1007/s00268-014-2648-2 Get It

Outcome of sleeve gastrectomy as a primary bariatric procedure (Br J Surg 2014; 101: 661–668)
Sarr, Michael G.

Mayo Clinic

British Journal of Surgery | April 11, 2014 | Volume: 101 | Issue: 6 | Pages: 668-668

10.1002/bjs.9445 | PMID 24723020 Get It

Adipocyte Mitochondrial Function Is Reduced in Human Obesity Independent of Fat Cell Size
Yin, Xiao , Lanza, Ian R. , Swain, James , Sarr, Michael G. , Jensen, Michael D. , Nair, K. Sreekumaran , Lanza, Ian R

Mayo Clinic

The Journal of Clinical Endocrinology & Metabolism | November 26, 2013 | Volume: 99 | Issue: 2 | Pages: E209-E216

10.1210/jc.2013-3042 | PMID 24276464 Get It

Medical Indications for Weight-Loss Surgery in Adolescents
Sarr, Michael G.

Mayo Clinic

JAMA Pediatrics | November 4, 2013 | Volume: 168 | Issue: 1 | Pages: 11

10.1001/jamapediatrics.2013.4496 | PMID 24190664 Get It

Cytoskeletal modulation of sodium current in human jejunal circular smooth muscle cells
Strege, Peter R. , Rich, Adam , Ou, Yijun, Sarr, Michael G. , Farrugia, Gianrico , Holm, Adrian N. , Miller, Steven , Strege, Peter R

Mayo Clinic

American Journal of Physiology-Cell Physiology | May 14, 2013 | Volume: 284 | Issue: 1 | Pages: C60-C66

10.1152/ajpcell.00532.2001 | PMID 12475760 Get It

A Na+ current is present in human jejunal circular smooth muscle cells. The aim of the present study was to determine the role of the cytoskeleton in the regulation of the Na+ current. Whole cell currents were recorded by using standard patch-clamp techniques with Cs+ in the pipette to block K+currents. Cytochalasin D and gelsolin were used to disrupt the actin cytoskeleton and phalloidin to stabilize it. Colchicine was used to disassemble the microtubule cytoskeleton (and intermediate filaments) and paclitaxel to stabilize it. Acrylamide was used to disrupt the intermediate filament cytoskeleton. Perfusion of the recording chamber at 10 ml/min increased peak Na+ current recorded from jejunal smooth muscle cells by 27 ± 3%. Cytochalasin D and gelsolin abolished the perfusion-induced increase in Na+current, whereas incubation with phalloidin, colchicine, paclitaxel, or acrylamide had no effect. In conclusion, the Na+ current expressed in human jejunal circular smooth muscle cells appears to be regulated by the cytoskeleton. An intact actin cytoskeleton is required for perfusion-induced activation of the Na+ current.
The Natural History of the Incidentally Discovered Small Simple Pancreatic Cyst: Long-Term Follow-Up and Clinical Implications
Handrich, Stephen J., Hough, David M., Sarr, Michael G. , Fletcher, Joel G.

Mayo Clinic

American Journal of Roentgenology | February 28, 2013 | Volume: 184 | Issue: 1 | Pages: 20-23

10.2214/ajr.184.1.01840020 | PMID 15615944 Get It

Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesity
Guichelaar, Maureen M. J., Viker, Kimberly, Sanderson, Schuyler O., Malinchoc, Michael, Watt, K.D.S., Swain, J., Sarr, Michael G. , Gawrieh, Samer , Olivier, Michael , Krishnan, Arunkumar , Charlton, Michael

Mayo Clinic

Obesity | February 18, 2013 | Volume: 21 | Issue: 9 | Pages: 1935-1941

10.1002/oby.20327 | PMID 23418085 Get It

Objective: Allelic variation (rs738409C→G) in adiponutrin (patatin‐like phospholipase domain‐containing protein 3, PNPLA3) has been associated with hepatic steatosis and liver fibrosis. The physiologic impact of the PNPLA3 G allele may be exacerbated in patients with severe obesity. In this study, we investigated the interactions of PNPLA3 rs738409 with a broad panel of metabolic and histologic characteristics of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis (NASH) in patients with medically complicated obesity.Design and Methods: Consecutive patients undergoing bariatric surgery were selected for a prospective study. They underwent extensive laboratory and histologic (liver biopsy) assessment, as well as evaluation of rs738409 polymorphism by TaqMan assay.Results: Only 12 (8.3%) of the 144 patients had normal liver histology, with 72 (50%) NASH, of whom 15 (10.4% of total patients) had fibrosis stage 2‐3. PNPLA3 GG genotype correlated positively (P < 0.05) with serum levels of alanine aminotransferase (ALT), asparate aminotransferase (AST), glucose, fibrinogen, and insulin‐dependent diabetes mellitus, homeostasis model assessment—insulin resistance, and presence of NASH. Multivariate analysis indicated that PNPLA3 rs738409 G versus C allele remained an (independent) risk factor for NASH, in addition to CK‐18 >145 IU/l, glucose >100 mg/dl, and C‐reactive protein (CRP) >0.8 mg/dl. The probability of NASH increased from 9% (no risk factor) to 82% if all four risk factors were present.Conclusions: In this cohort of patients with medically complicated obesity, PNPLA3 rs738409 G allelic expression is associated with hepatic (NASH) and nonhepatic complications of obesity, such as insulin resistance. These novel findings may be related to a greater impact of PNPLA3 variant in magnitude and scope in patients with severe obesity than in less obese populations. Further studies are needed to characterize the nature of these associations.
Risk perception of obesity and bariatric surgery in patients seeking treatment for obesity
Prasad, Chaithra , Clark, Matthew M. , Sarr, Michael G. , Collazo–Clavell, Maria L. , Batsis, John A. , López-Jiménez, Francisco , Somers, Virend K.

Mayo Clinic

European Journal of Preventive Cardiology | November 3, 2012 | Volume: 21 | Issue: 6 | Pages: 692-703

10.1177/2047487312466904 | PMID 23125401 Get It

A controlled study of peripheral neuropathy after bariatric surgery
Thaisetthawatkul, Pariwat , Collazo–Clavell, Maria L. , Sarr, Michael G. , Norell, Jane E., Dyck, Peter James

Mayo Clinic

Neurology | May 13, 2012 | Volume: 63 | Issue: 8 | Pages: 1462-1470

10.1212/01.wnl.0000142038.43946.06 | PMID 15505166 Get It